AI-generated summary
This prospective open-label study of 64 patients with moderate to severe evaporative dry eye from meibomian gland dysfunction assessed two intense pulsed light treatment sessions three weeks apart. The authors report significant improvements at day 42 in symptom scores, quality of vision, tear film stability and meibomian gland measures, while corneal staining and redness showed non-significant changes. The study had no control group, so the authors' conclusions cannot separate treatment effects from other influences.
- Participants
- 64
- Who or what was studied
- Patients with moderate to severe evaporative dry eye owing to meibomian gland dysfunction (64 patients, 128 eyes; mean age 36.09 years)
- Limits stated in the abstract
- The study was open-label and had no control group, and the abstract does not describe a comparison arm.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.sagepub.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Dry eye, Open-label study. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.